Zhejiang Curaway Medical Technology Co., Ltd

Established in 2014 and based in Hangzhou, China, the company's business covers four major fields: minimally invasive tumor, peripheral intervention, fine surgery, and intelligent medicine. There are 4 production bases under the company, creating a group operation mode integrating research and development, production, sales and service. Now the company has ten thousand and one hundred thousand level purification workshops, all purification workshops are designed and constructed according to the national pharmaceutical GMP standard. In February 2022, Zhejiang Curaway Medical Technology Co.

, Ltd raised series B funding led by new investor Hangzhou Industrial Investment Group, with participation from new investor Haier Capital. Zhejiang Curaway Medical Technology Co. , Ltd's products and solutions include four main areas: puncture biopsy, interventional positioning, minimally invasive treatment, and artificial intelligence. The puncture biopsy including percutaneous biopsy needle; the interventional positioning including single-use guide, suitable for clinical assistance in guiding target location puncture under the guidance of CT and other medical imaging equipment; the minimally invasive treatment including radiofrequency ablation therapy system and intravenous radiofrequency therapy system; the artificial intelligence including robot navigation, big data algorithms and image recognition capabilities.

The company’s revenue is generated primarily from the sale of its medical devices and equipment to hospitals, clinics, and other healthcare providers. The revenue model also includes maintenance and support services for its products, as well as income from research and development collaborations.